Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7554)
All Articles published online
|
Nov 28, 2011 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 2011; 17(44): 4853-4857 [PMID: 22171125 DOI: 10.3748/wjg.v17.i44.4853] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i44/4853.htm |
| Number | Citing Articles |
| 1 |
Thomas R. Jerrells. Commentary with Regard to the Role of Alcohol and Cofactors in the Development of Hepatocellular Carcinoma. Alcoholism: Clinical and Experimental Research 2012; 36(4): 564 doi: 10.1111/j.1530-0277.2012.01780.x
|
| 2 |
Guo-Hua Qiu, Xiaojin Xie, Fang Xu, Xiaohao Shi, Yue Wang, Linhong Deng. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B. Cytotechnology 2015; 67(1): 1 doi: 10.1007/s10616-014-9761-9
|
| 3 |
Ruirui Xu, Mingyan Xu, Yucai Fu, Xiaoling Deng, Hui Han, Xihe Chen, Wenjing He, Gengzhen Chen. Transforming growth factor‑β1 and lysophosphatidic acid activate integrin β6 gene promoter in Hep‑3B cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8672
|
| 4 |
Jiyoon Park, An K. Le, Tai-Chung Tseng, Ming-Lun Yeh, Dae Won Jun, Huy Trinh, Grace L.H. Wong, Chien-Hung Chen, Cheng-Yuan Peng, Sung Eun Kim, Hyunwoo Oh, Min-Sun Kwak, Ka Shing Cheung, Hidenori Toyoda, Yao-Chun Hsu, Jae Yoon Jeong, Eileen L. Yoon, Teerapat Ungtrakul, Jian Zhang, Qing Xie, Sang Bong Ahn, Masaru Enomoto, Jae-Jun Shim, Chris Cunningham, Soung Won Jeong, Yong Kyun Cho, Eiichi Ogawa, Rui Huang, Dong-Hyun Lee, Hirokazu Takahashi, Pei-Chien Tsai, Chung-Feng Huang, Chia-Yen Dai, Cheng-Hao Tseng, Satoshi Yasuda, Ritsuzo Kozuka, Jiayi Li, Christopher Wong, Clifford C. Wong, Changqing Zhao, Joseph Hoang, Yuichiro Eguchi, Chao Wu, Yasuhito Tanaka, Ed Gane, Tawesak Tanwandee, Ramsey Cheung, Man-Fung Yuen, Hyo-Suk Lee, Ming-Lung Yu, Jia-Horng Kao, Hwai-I Yang, Mindie H. Nguyen. Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. Clinical Gastroenterology and Hepatology 2022; 20(4): 874 doi: 10.1016/j.cgh.2021.05.062
|
| 5 |
Su Hwan Kim, Ji Won Kim, Kook Lae Lee, Seohui Lee, Seong-Joon Koh, Ji Bong Jeong, Byeong Gwan Kim. Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma. The American Journal of the Medical Sciences 2018; 356(2): 141 doi: 10.1016/j.amjms.2018.04.016
|
| 6 |
Irene Rapti, Stephanos Hadziyannis. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. World Journal of Hepatology 2015; 7(8): 1064-1073 doi: 10.4254/wjh.v7.i8.1064
|
| 7 |
Gaetano Scotto, Vincenzina Fazio, Coppola Nicola. Occult Hepatitis B Infection in Recent Immigrants to Italy: Occult B Infection in Immigrants. Journal of Community Health 2020; 45(2): 357 doi: 10.1007/s10900-019-00746-2
|
| 8 |
Yamin Liu, Mei Wang, Yunquan luo, Jian Chen, Yiyu lu, Yulin Shi, Chenchen Tang, Qianmei Zhou, Hui Zhang, Yuanjia Hu, Shibing Su, Qilong Chen. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11351-5
|
| 9 |
Salman Wahib Srayaldeen, Mohamed Ahmed Mohamed Elkhalifa. Cancer Care in the United Arab Emirates. 2024; : 491 doi: 10.1007/978-981-99-6794-0_30
|
| 10 |
Scott Bowden, Stephen Locarnini, Ting-Tsung Chang, You-Chen Chao, Kwang-Hyub Han, Robert G Gish, Robert A de Man, Miao Yu, Cyril Llamoso, Hong Tang. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World Journal of Gastroenterology 2015; 21(15): 4644-4651 doi: 10.3748/wjg.v21.i15.4644
|
| 11 |
Carina Rosenberg, Nicolai V. Bovin, Lone Valentin Bram, Eigil Flyvbjerg, Mogens Erlandsen, Thomas Vorup-Jensen, Eskild Petersen. Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Human Vaccines & Immunotherapeutics 2013; 9(7): 1466 doi: 10.4161/hv.24480
|
| 12 |
Chuanfang Luo, Shuhui Yu, Jinping Zhang, Xingrao Wu, Zhongyan Dou, Zheng Li, E. Yang, Lan Zhang. Hepatitis B or C viral infection and the risk of cervical cancer. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00466-8
|
| 13 |
Chuanxi Wang, Guanzhen Li, Jiamei Li, Jie Li, Tao Li, Jinyu Yu, Chengyong Qin. Overexpression of the metastasis‐associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2017; 32(8): 1525 doi: 10.1111/jgh.13680
|
| 14 |
Xing Yao, Huazong Zeng, Guolei Zhang, Weimin Zhou, Qiang Yan, Licheng Dai, Xiang Wang. The Associated Ion between the VDR Gene Polymorphisms and Susceptibility to Hepatocellular Carcinoma and the Clinicopathological Features in Subjects Infected with HBV. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/953974
|
| 15 |
Yan Du, Xue Han, Rui Pu, Jiaxin Xie, Yuwei Zhang, Guangwen Cao. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Frontiers of Medicine 2014; 8(2): 217 doi: 10.1007/s11684-014-0326-2
|
| 16 |
Kapil Dhingra, Sandeep Ratra, Amit Tanwar, Munesh Kumar, Mukesh Jain, Gaurav Gupta, Shivi Nijhawan, Hemendra Bharadwaj, Manisha Nijhawn, Sandeep Nijhawan. Prevalence of Hepatitis B and Hepatitis C Among School Children of Urban and Rural Jaipur, Rajasthan. Journal of Clinical and Experimental Hepatology 2020; 10(3): 272 doi: 10.1016/j.jceh.2019.11.006
|
| 17 |
Manoochehr Makvandi. Update on occult hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(39): 8720-8734 doi: 10.3748/wjg.v22.i39.8720
|
| 18 |
Yihui Rong, Haihan Song, Shaoli You, Bing Zhu, Hong Zang, Yi Zhao, Yongli Li, Zhihong Wan, Hongling Liu, Aimin Zhang, Long Xiao, Shaojie Xin. Association of Toll-like Receptor 3 Polymorphisms with Chronic Hepatitis B and Hepatitis B-Related Acute-on-Chronic Liver Failure. Inflammation 2013; 36(2): 413 doi: 10.1007/s10753-012-9560-4
|
| 19 |
Tian Yao, Yuanting Wu, Shuang Dong, Linying Gao, Shan Shi, Zhihong Shao, Lina Wu, Dan Feng, Jing Shi, Yawei Zhang, Yongliang Feng, Xiaofeng Liang, Suping Wang. Long-term durability of immunogenicity induced by standard and triple-dose hepatitis B vaccine in patients receiving methadone maintenance treatment. Expert Review of Vaccines 2020; 19(9): 785 doi: 10.1080/14760584.2020.1813577
|
| 20 |
F. Cai, Y. Zhao, Q. Chen, Y. Hu, Shibing Su, Yiyu Lu. Serum Cytokine Analysis Reveals Predictors of Progression from Chronic Hepatitis B to Liver Cirrhosis. Folia Biologica 2021; 67(1): 28 doi: 10.14712/fb2021067010028
|
| 21 |
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
|
| 22 |
Xia Liu, Cong Li, Jie Zhu, Wenshuai Li, Qiang Zhu. Dysregulation of FTX/miR‐545 signaling pathway downregulates Tim‐3 and is responsible for the abnormal activation of macrophage in cirrhosis. Journal of Cellular Biochemistry 2019; 120(2): 2336 doi: 10.1002/jcb.27562
|
| 23 |
Nam Hee Kim, Hong Joo Kim, Ji Hun Kang. Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study. The Korean Journal of Internal Medicine 2023; 38(6): 844 doi: 10.3904/kjim.2023.197
|
| 24 |
A. Loglio, M. Iavarone, G. Grossi, M. Viganò, MG. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico. Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B. Alimentary Pharmacology & Therapeutics 2018; 48(4): 431 doi: 10.1111/apt.14848
|
| 25 |
Qiuyan Liu, Yuanyuan Zheng, Yizhi Yu, Qinchun Tan, Xinping Huang. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C64–72 from hepatitis B virus core protein. International Immunopharmacology 2012; 13(2): 141 doi: 10.1016/j.intimp.2012.03.018
|
| 26 |
Zhengzhong Ni, Jun Lu, Weiyi Huang, Hanif Khan, Xuejun Wu, Danmei Huang, Ganggang Shi, Yongdong Niu, Haihua Huang. Transcriptomic identification of HBx-associated hub genes in hepatocellular carcinoma. PeerJ 2021; 9: e12697 doi: 10.7717/peerj.12697
|
| 27 |
Ping Chen, Chengbo Yu, Wei Wu, Jinghua Wang, Bing Ruan, Jingjing Ren, Shigui Yang, Kaijin Xu, Liang Yu, Lanjuan Li. Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study. Hepatitis Monthly 2013; 13(1) doi: 10.5812/hepatmon.7604
|
| 28 |
Sara BATTISTELLA, Erica N. LYNCH, Martina GAMBATO, Alberto ZANETTO, Monica PELLONE, Sarah SHALABY, Salvatore S. SCIARRONE, Alberto FERRARESE, Giacomo GERMANI, Marco SENZOLO, Patrizia BURRA, Francesco P. RUSSO. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy. Minerva Gastroenterology 2021; 67(1) doi: 10.23736/S2724-5985.20.02791-9
|
| 29 |
Anil Arora, Praveen Sharma, Pankaj Tyagi, Vikas Singla, Veronica Arora, Naresh Bansal, Jay Toshniwal, Ashish Kumar. Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India. Journal of Clinical and Experimental Hepatology 2013; 3(4): 288 doi: 10.1016/j.jceh.2013.08.007
|
| 30 |
Christine A. Bellezza, Sandra Sexton, Leslie I. Curtin, Patrick W. Concannon, Betty H. Baldwin, Lou Ann Graham, William E. Hornbuckle, Lois Roth, Bud C. Tennant. Laboratory Animal Medicine. 2015; : 351 doi: 10.1016/B978-0-12-409527-4.00008-0
|
| 31 |
Cong-Jun Wang, Lin Tang, Dong-Wei Shen, Chao Wang, Qiong-Ying Yuan, Wei Gao, Yong-Kun Wang, Rong-Hua Xu, Hui Zhang. The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma. Molecular Biology Reports 2013; 40(12): 6525 doi: 10.1007/s11033-013-2581-8
|
| 32 |
Hao Zheng, Sen Yang, Yuan Yang, Sheng-Xian Yuan, Fu-Quan Wu, Li-Li Wang, Hong-Li Yan, Shu-Han Sun, Wei-Ping Zhou. Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2015; 141(7): 1195 doi: 10.1007/s00432-014-1871-4
|
| 33 |
Li Qu, Hui Chen, Guoliang Wang, Jianfeng Wei. Frequent Losses of Heterozygosity in the Mitofusin 2 Gene in Hepatocellular Carcinoma: Their Relationship to Clinicopathological Features. Tumori Journal 2013; 99(6): 697 doi: 10.1177/030089161309900609
|
| 34 |
Nicholas Johnson. The Role of Animals in Emerging Viral Diseases. 2014; : 1 doi: 10.1016/B978-0-12-405191-1.00001-6
|
| 35 |
Joan Nankya-Mutyoba, Jim Aizire, Fredrick Makumbi, Ponsiano Ocama, Gregory D. Kirk. Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy. BMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4516-0
|
| 36 |
Mostafa Roshanravan, Zakiyeh Amini, Mohammad Reza Safdari, Sahar Kamel, Seyed Mohammad Javadzadeh, Hasan Namdar Ahmadabad. Impact of Serum 25(OH) D Levels on Immune Responses to Hepatitis B Virus Vaccination in Healthy Adults: A Cross-Sectional Study in Mane and Samalghan City. Infection Epidemiology and Microbiology 2023; 9(2): 157 doi: 10.61186/iem.9.2.157
|
| 37 |
Tong Liu, Chunhua Song, Youcheng Zhang, Sarah Tan Siyin, Qi Zhang, Mengmeng Song, Liying Cao, Hanping Shi. Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. International Journal of Cancer 2022; 150(6): 1018 doi: 10.1002/ijc.33891
|
| 38 |
Hendra Susanto, I. Kade Karisma Gita Ardana, Melati Putri Pertiwi, Elhah Nailul Khasna, Abdul Ghofur, Adeodatus Yuda Handaya, Nia Lukita Ariani. Computational study of betatrophin/ANGPTL8 and HBV interaction on lipoprotein lipase activity in the development of hepatocellular carcinoma caused by metabolic syndrome-related HBV infection. PROCEEDINGS OF THE 3RD INTERNATIONAL SEMINAR ON METALLURGY AND MATERIALS (ISMM2019): Exploring New Innovation in Metallurgy and Materials 2020; 2232: 040009 doi: 10.1063/5.0002471
|
| 39 |
Asmaa I Gomaa, Imam Waked. Recent advances in multidisciplinary management of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(4): 673-687 doi: 10.4254/wjh.v7.i4.673
|
| 40 |
Y.‐H. Rong, Z.‐H. Wan, H. Song, Y.‐L. Li, B. Zhu, H. Zang, Y. Zhao, H.‐L. Liu, A.‐M. Zhang, L. Xiao, S.‐J. Xin, S.‐L. You. Tim‐3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer‐like T cells in patients with chronic hepatitis B. Tissue Antigens 2014; 83(2): 76 doi: 10.1111/tan.12278
|
| 41 |
Qilong Chen, Feizhen Wu, Mei Wang, Shu Dong, Yamin Liu, Yiyu Lu, Yanan Song, Qianmei Zhou, Ping Liu, Yunquan Luo, Shibing Su. Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis. International Journal of Molecular Sciences 2016; 17(6): 883 doi: 10.3390/ijms17060883
|
| 42 |
Jaime Morales-Romero, Gustavo Vargas, Rebeca García-Román. Occult HBV Infection: A Faceless Enemy in Liver Cancer Development. Viruses 2014; 6(4): 1590 doi: 10.3390/v6041590
|
| 43 |
Marianna Hösel, Maria Quasdorff, Marc Ringelhan, Hamid Kashkar, Svenja Debey-Pascher, Martin F. Sprinzl, Jan-Hendrik Bockmann, Silke Arzberger, Dennis Webb, Gesa von Olshausen, Achim Weber, Joachim L. Schultze, Hildegard Büning, Mathias Heikenwalder, Ulrike Protzer. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(3): 339 doi: 10.1016/j.jcmgh.2017.07.003
|
| 44 |
I-Cheng Lu, Mei-Chu Yen Jean, Chi-Wei Lin, Wei-Hung Chen, Daw-Shyong Perng, Chih-Wen Lin, Hung-Yi Chuang. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine. Medicine 2016; 95(39): e5023 doi: 10.1097/MD.0000000000005023
|
| 45 |
Tina Boortalary, Brianna Shinn, Dina Halegoua-DeMarzio, Hie-Won Hann. Liver Cancer. 2021; : 109 doi: 10.36255/exonpublications.livercancer.2021.ch6
|
| 46 |
Cecilia María Delfino, Emiliano Alberto Gentile, Amalia Inés Castillo, María Luján Cuestas, Gabriela Pataccini, Camila Cánepa, Richard Malan, Jorgelina Blejer, Carolina Berini, María Emilia Eirin, Williams Pedrozo, José Raúl Oubiña, Mirna Marcela Biglione, Verónica Lidia Mathet. Hepatitis B virus and hepatitis D virus in blood donors from Argentina: circulation of HBsAg and reverse transcriptase mutants. Archives of Virology 2014; 159(5): 1109 doi: 10.1007/s00705-013-1917-y
|
| 47 |
Vidya Vedham, Rao L. Divi, Vaurice L. Starks, Mukesh Verma. Multiple Infections and Cancer: Implications in Epidemiology. Technology in Cancer Research & Treatment 2014; 13(2): 177 doi: 10.7785/tcrt.2012.500366
|
| 48 |
Kenny Roose, Sarah De Baets, Bert Schepens, Xavier Saelens. Hepatitis B core–based virus–like particles to present heterologous epitopes. Expert Review of Vaccines 2013; 12(2): 183 doi: 10.1586/erv.12.150
|
| 49 |
CHENG-LIANG ZHU, DUO-ZHI CHENG, FANG LIU, XIAO-HONG YAN, KAI-LANG WU, FU-BING WANG, XING-HUI LIU. Hepatitis B virus upregulates the expression of kinesin family member 4A. Molecular Medicine Reports 2015; 12(3): 3503 doi: 10.3892/mmr.2015.3792
|
| 50 |
Xiaofan You, Fen Jiang, Yiliang Zhang. Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a. Biotechnology and Genetic Engineering Reviews 2024; 40(3): 2803 doi: 10.1080/02648725.2023.2202531
|
| 51 |
Maura Dandri, Joerg Petersen. Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential. Clinical Infectious Diseases 2016; 62(suppl 4): S281 doi: 10.1093/cid/ciw023
|
| 52 |
X-L Wei, M-Z Qiu, Y Jin, Y-X Huang, R-Y Wang, W-W Chen, D-S Wang, F Wang, H-Y Luo, D-S Zhang, F-H Wang, Y-H Li, R-H Xu. Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases. British Journal of Cancer 2015; 112(7): 1283 doi: 10.1038/bjc.2014.406
|
| 53 |
Mohammed Amin Mohammed, Hany Shabana, Tarek Sheta, Nesreen Moustafa Omar, Soad Amin Mohammed. Vitamin D Receptor Gene Polymorphisms as a Predictive Risk Factor for Hepatocellular Carcinoma Development and Severity in Chronic Hepatitis B. International Journal of Cancer Research 2016; 13(1): 26 doi: 10.3923/ijcr.2017.26.35
|
| 54 |
Wasit WONGTRAKUL, Nipith CHAROENNGAM, Ben PONVILAWAN, Pongprueth RUJIRACHUN, Phuuwadith WATTANACHAYAKUL, Thitiphan SRIKULMONTRI, Nutchaphon HONG, Pavarist RAI, Patompong UNGPRASERT. Hepatitis B virus infection and risk of gastric cancer: a systematic review and meta-analysis. Minerva Gastroenterology 2024; 69(4) doi: 10.23736/S2724-5985.21.02946-6
|
| 55 |
Moses T. Bility, Liang Cheng, Zheng Zhang, Yan Luan, Feng Li, Liqun Chi, Liguo Zhang, Zhengkun Tu, Yanhang Gao, Yangxin Fu, Junqi Niu, Fusheng Wang, Lishan Su, Christopher M. Walker. Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages. PLoS Pathogens 2014; 10(3): e1004032 doi: 10.1371/journal.ppat.1004032
|
| 56 |
Xiang-Qian Gu, Wei-Ping Zheng, Da-Hong Teng, Ji-San Sun, Hong Zheng. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World Journal of Gastroenterology 2016; 22(9): 2749-2759 doi: 10.3748/wjg.v22.i9.2749
|
| 57 |
Gang Luo, Ning-Bo Hao, Chang-Jiang Hu, Xin Yong, Mu-Han Lü, Bo-Jun Cheng, Yao Zhang, Shi-Ming Yang. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes & Control 2013; 24(3): 529 doi: 10.1007/s10552-012-0144-2
|
| 58 |
Yi-Yu Lu, Qi-Long Chen, Yan Guan, Zhi-Zhong Guo, Hui Zhang, Wei Zhang, Yi-Yang Hu, Shi-Bing Su. Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis. Mol. BioSyst. 2014; 10(5): 1117 doi: 10.1039/C3MB70474B
|
| 59 |
Anaïs Vallet‐Pichard, Stanislas Pol. Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2021; 53(11): 1166 doi: 10.1111/apt.16356
|
| 60 |
Livia Melo Villar, Luciane Almeida Amado, Adilson José de Almeida, Vanessa Salete de Paula, Lia Laura Lewis-Ximenez, Elisabeth Lampe. Low Prevalence of Hepatitis B and C Virus Markers among Children and Adolescents. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/324638
|
| 61 |
Andy Hong, Dong Dong Han, Christine J. Wright, Tanya Burch, Jessica Piper, Carla Osiowy, Chunjin Gao, Shirley Chiang, Travis Magill, Kevin Dick, Timothy F. Booth, Xuguang Li, Runtao He. The interaction between hepatitis B virus X protein and AIB1 oncogene is required for the activation of NFκB signal transduction. Biochemical and Biophysical Research Communications 2012; 423(1): 6 doi: 10.1016/j.bbrc.2012.05.021
|
| 62 |
Mohit Mittal, Ke-Qin Hu. Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection. Current Hepatology Reports 2017; 16(2): 90 doi: 10.1007/s11901-017-0339-9
|